An expanding role for cell biologists in drug discovery and pharmacology
暂无分享,去创建一个
[1] D. Gary Gilliland,et al. Drug development and clinical trials—the path to an approved cancer drug , 2012, Nature Reviews Clinical Oncology.
[2] Ravi Iyengar,et al. Network analyses in systems pharmacology , 2009, Bioinform..
[3] Timothy J. Mitchison,et al. The proliferation rate paradox in antimitotic chemotherapy , 2012, Molecular biology of the cell.
[4] Ralph Weissleder,et al. Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics. , 2011, Cancer research.
[5] Charles C. Persinger,et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.
[6] A. Barabasi,et al. Systems biology and the future of medicine , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.
[7] I-Ming Wang,et al. Systems biology approach for new target and biomarker identification. , 2013, Current topics in microbiology and immunology.
[8] C. Sigman,et al. Cancer biomarkers: selecting the right drug for the right patient , 2012, Nature Reviews Drug Discovery.
[9] P. Chène. Can biochemistry drive drug discovery beyond simple potency measurements? , 2012, Drug discovery today.
[10] D. Huszar,et al. Kinesin motor proteins as targets for cancer therapy , 2009, Cancer and Metastasis Reviews.
[11] A. Letai,et al. Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy , 2011, Science.
[12] R. Lalonde,et al. Introduction of Quantitative Methods in Pharmacology and Clinical Pharmacology: A Historical Overview , 2007, Clinical pharmacology and therapeutics.
[13] Malorye Allison,et al. NCATS launches drug repurposing program , 2012, Nature Biotechnology.